SMAD3 AND SMAD4: NOVEL INHIBITORS OF ETV1-DEPENDENT PROSTATE CANCER DEVELOPMENT

$123,894FY2013Department of DefenseDOD

University Of Oklahoma, Norman OK

Investigators

View source on USAspending →